Confirmed, pooled, blinded COVID-19 events in the ongoing Phase 3 DECLARATION study of VYD2311 accumulated to date (~ 50% of study progress) can ...

Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today announced participation in the following scientific a ...

Karim, Executive Vice President of Integrated Marketing and Communications, EEMEA at Mastercard, makes the case for a passion ...

A regulatory veterinarian, a laboratory director, and an equine researcher shared the stage — not as a punchline, but as an ...

Radix recently announced Rush 2026, a strategic initiative designed to move artificial intelligence from experimental ...

In 2025, 56.9% of all the pitches Senzatela threw were four seam fastballs. He did that despite that pitch having the second ...

Gregory McVay, group vice president and chief customer officer at Danaher Life Sciences, discusses how automation and AI can ...

Many claim to have ‘saltwater in their veins,’ but all you have to do is walk into the corner office of John McDonald, the ...

A cheerleader for the very real-world magic of psychedelics, Michael Pollan talks about his new journey to the heart of ...

Seer Inc. SEER on Thursday said its Proteograph Product Suite will serve as the mass spectrometry-based workflow to profile ...

Southeast Asia Blood Glucose Monitoring Market was valued at ~USD 545.20 million in 2024 and is expected to grow at a strong ...